Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()

Dysregulation of S100A8 is described in many different human tumor types, but its role in prostate cancer is unknown. To evaluate the clinical relevance of S100A8 expression in prostate cancer, a tissue microarray containing 13,665 tumors was analyzed by immunohistochemistry. Cytoplasmic S100A8 stai...

Descripción completa

Detalles Bibliográficos
Autores principales: Minner, Sarah, Hager, Dominik, Steurer, Stefan, Höflmayer, Doris, Tsourlakis, Maria Christina, Möller-Koop, Christina, Clauditz, Till S, Hube-Magg, Claudia, Luebke, Andreas M, Simon, Ronald, Sauter, Guido, Göbel, Cosima, Weidemann, Sören, Lebok, Patrick, Dum, David, Fraune, Christoph, Izbicki, Jakob, Burandt, Eike, Schlomm, Thorsten, Huland, Hartwig, Heinzer, Hans, Haese, Alexander, Graefen, Markus, Heumann, Asmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698296/
https://www.ncbi.nlm.nih.gov/pubmed/31382165
http://dx.doi.org/10.1016/j.neo.2019.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698296/
https://www.ncbi.nlm.nih.gov/pubmed/31382165
http://dx.doi.org/10.1016/j.neo.2019.07.003

Ejemplares similares